A Conversation About Personalized Medicine with Luba Greenwood

Lis Agosto (Research Analyst at Global X ETFs) sits down with Luba Greenwood (CEO of Kojin Therapeutics) to discuss the state of the healthcare industry today and where it is headed.

https://partners.wsj.com/global-x-etfs/charting-disruption/personalized-medicine